TNXP
NASDAQ · Biotechnology
Tonix Pharmaceuticals Holdin
$3.01
-0.23 (-7.10%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,253.5% upside
Low Target
$28.14
Average Target
$40.74
High Target
$50.62
Current Price
$3.01
Current
$3.01
$3.01
Target
$40.74
$40.74
$28.14
$40.74 avg
$50.62
Scenario Analysis
Bear Case
$28.14
834.9%
Low target
Base Case
$40.74
+1,253.5%
Avg target
Bull Case
$50.62
+1,581.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$20.56
-85.4% from high
52-Week Low
$3.21
+-6.2% from low
Target vs 52W High
$40.74
+98.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |